![]() |
Volumn 1160, Issue 1-2, 2007, Pages 21-33
|
Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine
|
Author keywords
Alendronate; Biphosphonates; Derivatization; HPLC MS MS; Pharmacokinetics; Reversed phase; Urine
|
Indexed keywords
BIPHOSPHONATES;
ION-PAIR CHROMATOGRAPHY;
POLAR COMPOUNDS;
DRUG PRODUCTS;
ELECTROSPRAY IONIZATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PHARMACOKINETICS;
SALTS;
SENSITIVITY ANALYSIS;
BODY FLUIDS;
ALENDRONIC ACID;
CLODRONIC ACID;
ETIDRONIC ACID;
PAMIDRONIC ACID;
ANALYTIC METHOD;
ARTICLE;
DERIVATIZATION;
DRUG BIOAVAILABILITY;
DRUG URINE LEVEL;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
ION PAIR CHROMATOGRAPHY;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
SINGLE DRUG DOSE;
URINARY EXCRETION;
ALENDRONATE;
BIOLOGICAL AVAILABILITY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CLODRONIC ACID;
DIPHOSPHONATES;
ETIDRONIC ACID;
HUMANS;
MASS SPECTROMETRY;
REFERENCE STANDARDS;
|
EID: 34447530814
PISSN: 00219673
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chroma.2007.04.020 Document Type: Article |
Times cited : (44)
|
References (10)
|